Early detection of cardiotoxicity in chemotherapy-treated patients from real-time 3D echocardiography

Computing in Cardiology

Volumn 40, Issue , 2013, Pages 249-252

  Lorenzini, Cinzia ^a   Corsi, Cristiana ^a   Aquilina, Michele ^b   Casadei Gardini, Andrea ^b   Rocca, Andrea ^b   Frassineti, Luca ^b   Scarpi, Emanuela ^b   Amadori, Dino ^b   Lamberti, Claudio ^a  

^a UNIVERSITY OF BOLOGNA   (Italy)

^b DEPARTMENT OF MEDICAL ONCOLOGY   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84894172694     PISSN: 23258861     EISSN: 2325887X     Source Type: Conference Proceeding    
DOI: None     Document Type: Conference Paper

References (10)

1. [I] Biswas M, Sudhakar S, Nanda NC, Buckberg G, Pradhan M, Roomi AU, Gorissen W, Houle H. Two- and three-dimensional speckle tracking echocardiography: Clinical Applications and Future Directions. Echocardiography Echocardiography 2013;30(1):88-105.
2. Mor-avi V, Lang RM. Is echocardiography reliable for monitoring the adverse cardiac effects of chemotherapy? JACC 2013;61(1):85-86.
3. Martin M, Esteva FJ, Alba E, Khandheria B, Perez-Isla L, Garcia-Saenz JA, Marquez A, Sengupta P, Zamorano J. Minimizing cardiotoxicity while optimizing treatment efficacy with trastuzumab: Review and expert recommendations. Oncologist 2009;14:1-11.
4. Lang RM, Mor-Avi V, Dent JM, Kramer CM. Three-dimensional echocardiography: is it ready for everyday clinical use? J Am Coil Cardiol Img 2009;2:114-117.
5. Thanvendiranatan P, Grant AD, Negishi T, Plana JC, Popovic ZB, Marwick TH. Reproducibility of echocardiographic techniques for sequential assessment of left ventricular ejection fraction and volumes. JACC 2013;61(1):77-84.
6. Sawaya H, Sebag IA, Plana JC, Januzzi JL, Ky B, Tan TC, Cohen V, Banchs J, Carver JR, Wiegers SE, Martin P, Picard MR, Gerszten RE, Halpern EF, Passeri J, Kuter I, Scherrer-Crosbie M. Assessment of echocardiography and biomarkers foe the extended prediction of cardiotoxicity in patients treated with anthracyclines, taxanes, and trastuzumab. Circ Cardiovasc Imaging 2012;5:596-603.
7. Hare J, Brown JK, Leano R, Jenkins C, Woodward N, Marwick TH. Use of myocardial deformation imaging to detect preclinical myocardial dysfunction before conventional measures in patients undergoing breast cancer treatment with trastuzumab. Am Heart J 2009;158(2):294-301.
8. Oreto L, Todaro MC, Umland MM, Kramer C, Qamar R, Carerj S, Khandheria BK, Paterick TE. Use of echocardiography to evaluate the cardia effects of therapies used in cancer treatment: what do we know? JASE 2012;25(11):1141-1152.
9. Fallah-Rad N, Walker JR, Wassef A, Lytwyn M, Bohonis S, Fang T, Tian G, Kirkpatrick ID, Singal PK, Krahn M, Grenier D, Jassal DS. The utility of cardiac biomarkers, tissue velocity and strain imaging, and cardiac magnetic resonance imaging in predicting early left ventricular dysfunction in patients with human epidermal growth factor receptor II-positive breast cancer treated with adjuvant trastuzumab therapy. J Am Coli Cardiol. 2011;57(22):2263-70.
10. Migrino RQ, Aggarwal D, Konorev E, Brahmbhatt T, Bright M, Kalyanaraman B. Early detection of doxorubicin cardiomyopathy using two-dimensional strain echocardiography. Ultrasound Med Biol 2008;34(2):208-14.